Enhanced bone morphogenetic protein‐2 performance on hydroxyapatite ceramic surfaces
Source abstract
Abstract
Abstract The immobilization of biomolecules on biomaterial surfaces allows for the control of their localization and retention. In numerous studies, proteins have been simply adsorbed to enhance the biological performance of various materials in vivo. We investigated the potential of surface modification techniques on hydroxyapatite (HA) ceramic discs in an in vitro approach. A novel method for protein immobilization was evaluated using the aminobisphosphonates pamidronate and alendronate, which are strong Ca chelating agents, and was compared with the established silanization technique. Lysozyme and bone morphogenetic protein‐2 (BMP‐2) were used to assess the suitability of the two surface modification methods with regard to the enzymatic activity of lysozyme and to the capacity of BMP‐2 to stimulate the osteoblastic differentiation of C2C12 mouse myoblasts. After immobilization, a 2.5‐fold increase in enzymatic activity of lysozyme wasobserved compared with the control. The alkaline phosphatase activity per cell stimulated by immobilized BMP‐2 was 2.5‐fold higher [9 × 10−6 I.U.] than the growth factor on unmodified surfaces [2–4 × 10−6 I.U.]. With regard to the increase in protein activity, both procedures lead to equivalent results. Thus, the bisphosphonate‐based surface modification represents a safe and easy alternative for the attachment of proteins to HA surfaces. © 2008 Wiley Periodicals, Inc. J Biomed Mater Res, 2009
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Bone Tissue Engineering Materials · Dental Implant Techniques and Outcomes · Orthopaedic implants and arthroplasty
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (70)
Show source-provided references
1. Puleo DA · 2004 · 190
2. 10.1016/S0142-9612(03)00339-910.1016/S0142-9612(03)00339-9 ↗
3. 10.1126/science.106740410.1126/science.1067404 ↗
4. 10.1016/j.ejpb.2004.03.00410.1016/j.ejpb.2004.03.004 ↗
5. 10.1097/00006534-199801000-0004010.1097/00006534-199801000-00040 ↗
6. 10.1080/0897719041233127989010.1080/08977190412331279890 ↗
7. 10.1111/j.1749-6632.2002.tb03067.x10.1111/j.1749-6632.2002.tb03067.x ↗
8. 10.1111/j.1551-2916.2005.00634.x10.1111/j.1551-2916.2005.00634.x ↗
9. 10.1016/j.bone.2005.06.01110.1016/j.bone.2005.06.011 ↗
10. 10.1002/jbm.a.1036210.1002/jbm.a.10362 ↗
11. 10.4028/www.scientific.net/KEM.240-242.66710.4028/www.scientific.net/KEM.240-242.667 ↗
12. 10.1016/S8756-3282(02)00740-810.1016/S8756-3282(02)00740-8 ↗
13. 10.1016/S0142-9612(02)00551-310.1016/S0142-9612(02)00551-3 ↗
14. 10.1016/j.jconrel.2005.04.01810.1016/j.jconrel.2005.04.018 ↗
15. 10.1002/(SICI)1097-4636(199908)46:2<193::AID-JBM8>3.0.CO;2-110.1002/(SICI)1097-4636(199908)46:2<193::AID-JBM8>3.0.CO;2-1 ↗
16. 10.1002/jbm.125810.1002/jbm.1258 ↗
17. 10.1002/1521-4052(200112)32:12<942::AID-MAWE942>3.0.CO;2-910.1002/1521-4052(200112)32:12<942::AID-MAWE942>3.0.CO;2-9 ↗
18. 10.1042/BA2005007510.1042/BA20050075 ↗
19. 10.1111/j.1151-2916.1991.tb07132.x10.1111/j.1151-2916.1991.tb07132.x ↗
20. 10.1002/1527-2648(200106)3:6<401::AID-ADEM401>3.0.CO;2-L10.1002/1527-2648(200106)3:6<401::AID-ADEM401>3.0.CO;2-L ↗
21. 10.1023/B:JMSM.0000032818.09569.d910.1023/B:JMSM.0000032818.09569.d9 ↗
22. Schuessele A · 2005 · 87
23. 10.1089/ten.1998.4.33710.1089/ten.1998.4.337 ↗
24. 10.1016/S0142-9612(01)00244-710.1016/S0142-9612(01)00244-7 ↗
25. 10.1016/8756-3282(95)00445-910.1016/8756-3282(95)00445-9 ↗
26. 10.1021/bp990154m10.1021/bp990154m ↗
27. 10.1021/bp000066y10.1021/bp000066y ↗
28. 10.1016/S8756-3282(98)00033-710.1016/S8756-3282(98)00033-7 ↗
29. 10.1016/j.biomaterials.2003.11.02410.1016/j.biomaterials.2003.11.024 ↗
30. 10.1016/j.bone.2005.05.00310.1016/j.bone.2005.05.003 ↗
31. 10.1016/j.biomaterials.2004.02.07210.1016/j.biomaterials.2004.02.072 ↗
32. 10.1016/j.biomaterials.2003.08.04910.1016/j.biomaterials.2003.08.049 ↗
33. 10.1016/S0142-9612(01)00339-810.1016/S0142-9612(01)00339-8 ↗
34. 10.1076/ocii.7.1.7.810810.1076/ocii.7.1.7.8108 ↗
35. 10.1083/jcb.127.6.175510.1083/jcb.127.6.1755 ↗
36. 10.1089/ten.2004.10.139910.1089/ten.2004.10.1399 ↗
37. 10.1089/ten.2004.10.141410.1089/ten.2004.10.1414 ↗
38. 10.1016/0032-3861(77)90164-110.1016/0032-3861(77)90164-1 ↗
39. 10.1016/S0001-8686(97)00040-710.1016/S0001-8686(97)00040-7 ↗
40. 10.1080/09205063.1991.975665910.1080/09205063.1991.9756659 ↗
41. 10.1021/la026690x10.1021/la026690x ↗
42. 10.1089/10763270376268755510.1089/107632703762687555 ↗
43. 10.1002/(SICI)1097-4636(19990905)46:3<390::AID-JBM12>3.0.CO;2-N10.1002/(SICI)1097-4636(19990905)46:3<390::AID-JBM12>3.0.CO;2-N ↗
44. 10.1002/(SICI)1097-4636(19980605)40:3<358::AID-JBM3>3.0.CO;2-E10.1002/(SICI)1097-4636(19980605)40:3<358::AID-JBM3>3.0.CO;2-E ↗
45. 10.1016/S0142-9612(98)00033-710.1016/S0142-9612(98)00033-7 ↗
46. 10.1016/S0142-9612(01)00070-910.1016/S0142-9612(01)00070-9 ↗
47. 10.1002/(SICI)1097-4636(19980605)40:3<490::AID-JBM20>3.0.CO;2-M10.1002/(SICI)1097-4636(19980605)40:3<490::AID-JBM20>3.0.CO;2-M ↗
48. 10.1016/S0076-6879(76)44012-010.1016/S0076-6879(76)44012-0 ↗
49. 10.1002/jbm.82029080610.1002/jbm.820290806 ↗
50. Modification of the silica surface with aminosilanes
51. 10.1021/ac001063310.1021/ac0010633 ↗
52. Biochemical surface modification of Ti‐6Al‐4V for the delivery of protein to the cell‐biomaterial interface
53. 10.1039/c3995000232310.1039/c39950002323 ↗
54. 10.1002/1097-4636(200107)56:1<9::AID-JBM1073>3.0.CO;2-210.1002/1097-4636(200107)56:1<9::AID-JBM1073>3.0.CO;2-2 ↗
55. 10.1007/BF0012140810.1007/BF00121408 ↗
56. 10.1016/j.biomaterials.2005.12.00810.1016/j.biomaterials.2005.12.008 ↗
57. MeyerJ NiesB DardM HoelzemannG KesslerH KantlehnerM HerselU GibsonC SulyokG.Peptide and peptide mimetic conjugates with integrin‐inhibitor properties and usage for the integration of prosthetic materials.2001;2001‐EP8932:38.
58. 10.1016/S0142-9612(01)00358-110.1016/S0142-9612(01)00358-1 ↗
59. The effect of the addition of a polyglutamate motif to RGD on peptide tethering to hydroxyapatite and the promotion of mesenchymal stem cell adhesion
60. 10.1002/jbm.1033810.1002/jbm.10338 ↗
61. 10.1016/0003-2697(90)90267-D10.1016/0003-2697(90)90267-D ↗
62. 10.1126/science.165.3892.45410.1126/science.165.3892.454 ↗
63. 10.1006/jmbi.1999.259010.1006/jmbi.1999.2590 ↗
64. 10.1002/jbm.a.3000610.1002/jbm.a.30006 ↗
65. 10.1002/jbm.82026080310.1002/jbm.820260803 ↗
66. 10.1016/0142-9612(96)80751-410.1016/0142-9612(96)80751-4 ↗
67. 10.1016/S0883-5403(06)80157-910.1016/S0883-5403(06)80157-9 ↗
68. 10.1002/jbm.a.3002810.1002/jbm.a.30028 ↗
69. 10.1016/S0142-9612(00)00234-910.1016/S0142-9612(00)00234-9 ↗
70. Bisphosphonates directly regulate cell proliferation, differentiation, and gene expression in human osteoblasts